摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[4-(1-benzyl-1H-benzimidazol-5-ylmethoxy)benzyl]thiazolidine-2,4-dione

中文名称
——
中文别名
——
英文名称
5-[4-(1-benzyl-1H-benzimidazol-5-ylmethoxy)benzyl]thiazolidine-2,4-dione
英文别名
5-[4-(1-Benzylbenzimidazol-5-ylmethoxy)benzyl]-thiazolidine-2,4-dione;5-[[4-[(1-Benzylbenzimidazol-5-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[4-(1-benzyl-1H-benzimidazol-5-ylmethoxy)benzyl]thiazolidine-2,4-dione化学式
CAS
——
化学式
C25H21N3O3S
mdl
——
分子量
443.526
InChiKey
ONODKHPBKXXABX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    32
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    98.5
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Therapeutic and prophylactic agents for neoplasms
    申请人:SANKYO COMPANY, LIMITED
    公开号:US20020137776A1
    公开(公告)日:2002-09-26
    This invention relates to therapeutic and prophylactic agents for neoplasms which comprise a fused heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient; to the use of such a compound in the preparation of a medicament for the treatment and prevention of neoplasms; and to a method for treatment and prevention of neoplasms which comprises administering a pharmaceutically effective amount of such a compound to a warm-blooded animal (preferably a human).
    本发明涉及治疗和预防肿瘤的治疗剂和预防剂,其包括融合的杂环化合物或其药学上可接受的盐作为活性成分;使用这种化合物制备治疗和预防肿瘤的药物;以及一种治疗和预防肿瘤的方法,其中将这种化合物的药学有效量注射到温血动物(最好是人类)中。
  • Composition for use in the treatment and prevention of hyperuricemia
    申请人:Sankyo Company Limited
    公开号:EP0919232A1
    公开(公告)日:1999-06-02
    Insulin sensitivity enhancers, such as troglitazone, have the ability to treat and/or prevent hyperuricemia and may thus be used for the therapy or prophylaxis of such diseases as gout, urinary calculus, hyperuricemic nephropathy and Lesch-Nyhan syndrome.
    曲格列酮等胰岛素敏感性增强剂具有治疗和/或预防高尿酸血症的能力,因此可用于痛风、尿路结石、高尿酸血症肾病和莱希-尼汉综合征等疾病的治疗或预防。
  • REMEDY FOR AUTOIMMUNE DISEASES
    申请人:Sankyo Company, Limited
    公开号:EP0953355A1
    公开(公告)日:1999-11-03
    A preventive or therapeutic agent for autoimmune diseases (excluding type I diabetes) contaning an insulin resistance improving substance as an active ingredient.
    一种预防或治疗自身免疫性疾病(I 型糖尿病除外)的制剂,含有一种改善胰岛素抵抗的物质作为活性成分。
  • PREVENTIVE AND THERAPEUTIC AGENTS FOR CANCER
    申请人:Sankyo Company, Limited
    公开号:EP1197211A1
    公开(公告)日:2002-04-17
    Fused heterocyclic compounds of formula (I): wherein X is benzimidazolyl which is optionally substituted with 1 to 5 substituents selected from Group A; Y is an oxygen or sulfur atom; Z is 2,4-dioxothiazolidin-5-ylmethyl or the like; R is hydrogen or the like; m is an integer from 1 to 5; and Group A is alkyl or the like; and pharmaceutically acceptable salts thereof are useful as therapeutic or prophylactic agents for cancer.
    式(I)的融合杂环化合物: 其中 X 是苯并咪唑基,可任选被 1 至 5 个选自 A 组的取代基取代;Y 是氧原子或硫原子;Z 是 2,4-二氧代噻唑啉-5-基甲基或类似物;R 是氢或类似物;m 是 1 至 5 的整数;A 组是烷基或类似物;其药学上可接受的盐类可用作癌症的治疗剂或预防剂。
  • Benzimidazole derivatives, their preparation and their therapeutic use
    申请人:SANKYO COMPANY LIMITED
    公开号:EP0745600B1
    公开(公告)日:2001-10-24
查看更多